ArticleBMJ global health2018
Production costs and potential prices for biosimilars of human insulin and insulin analogues.
Dzintars Gotham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled itcites it